Starlight Cardiovascular, Inc.
About Starlight Cardiovascular, Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: SBIR Phase II Grant T: - FT: SBIR Phase II Grant |
A: 1999870 MR: - FA: $1,999,870 FAN: 1999870 |
D: 2024-05-01 FD: 2024-05-01 |
1 investors |
| 2 |
RT: SBIR Phase II Grant T: - FT: SBIR Phase II Grant |
A: 2158183 MR: - FA: $2.16M FAN: 2158183 |
D: 2023-03-22 FD: 2023-03-22 |
1 investors |
Growth Metrics
Team & Leadership
Beverly Tang
Chief Executive Officer & Co-Founder
Darrin Kent
Vice President, Research & Development
Kathryn Olson
Vice President, Strategic & Product Marketing
Carl Berke
Co-Founder
Pedro del Nido
Co-founder
Tom Duerig
Co-Founder
Recent News
Starlight Cardiovascular, Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- starlightcardio.com
- Industries
- Healthcare
- Company Size
- ~280 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro